Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Humblet

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Acta Gastro-Enterologica Belgica|October 1, 1996
Severe anal condylomata acuminata following high-dose chemotherapy and autologous hematopoietic stem cell transplantation: a case reportL D'Hondt, B Filleul, T Guillaume, et al.
Cancer Research|September 15, 1989
Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autograftsY Humblet, A M Feyens, M Sekhavat, et al.
Annales D'Urologie|January 1, 1989
[Motor evoked potentials of the perineal floor. Preliminary results]R J Opsomer, P J Van Cangh, Y Humblet, et al.
Acta Chirurgica Belgica|November 1, 1994
Primary squamous-cell carcinoma of the colon: a case reportH Vraux, A Kartheuser, J Haot, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2011
Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinomaI Borbath, L Verbrugghe, R Lai, et al.
Acta Clinica Belgica|February 18, 2012
New drugs in medical oncology: new difficulties to distinguish drug-induced side effects from cancer complications: a case-reportE Seront, F Mazzeo, M Mano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clinique de l'Université Catholique de Louvain, Brussels and Liège, BelgiumH van de Velde, L Bosquée, P Weynants, et al.
British Journal of Cancer|March 1, 1996
Tallimustine in advanced previously untreated colorectal cancer, a phase II studyC J Punt, Y Humblet, E Roca, et al.
Acta Clinica Belgica|March 21, 2008
Bronchobiliary fistula and cholangiocarcinoma: a case report and principles of managementS Delande, P Goffette, C Verbaandert, et al.
Annals of Hematology|May 10, 2000
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patientsB Vandercam, J Gérain, Y Humblet, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Acta Gastro-Enterologica Belgica|October 1, 1996
Severe anal condylomata acuminata following high-dose chemotherapy and autologous hematopoietic stem cell transplantation: a case reportL D'Hondt, B Filleul, T Guillaume, et al.
Cancer Research|September 15, 1989
Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autograftsY Humblet, A M Feyens, M Sekhavat, et al.
Annales D'Urologie|January 1, 1989
[Motor evoked potentials of the perineal floor. Preliminary results]R J Opsomer, P J Van Cangh, Y Humblet, et al.
Acta Chirurgica Belgica|November 1, 1994
Primary squamous-cell carcinoma of the colon: a case reportH Vraux, A Kartheuser, J Haot, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2011
Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinomaI Borbath, L Verbrugghe, R Lai, et al.
Acta Clinica Belgica|February 18, 2012
New drugs in medical oncology: new difficulties to distinguish drug-induced side effects from cancer complications: a case-reportE Seront, F Mazzeo, M Mano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clinique de l'Université Catholique de Louvain, Brussels and Liège, BelgiumH van de Velde, L Bosquée, P Weynants, et al.
British Journal of Cancer|March 1, 1996
Tallimustine in advanced previously untreated colorectal cancer, a phase II studyC J Punt, Y Humblet, E Roca, et al.
Acta Clinica Belgica|March 21, 2008
Bronchobiliary fistula and cholangiocarcinoma: a case report and principles of managementS Delande, P Goffette, C Verbaandert, et al.
Annals of Hematology|May 10, 2000
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patientsB Vandercam, J Gérain, Y Humblet, et al.
Pageof 8